2m 2m 2m 2m 2m 2m 2m
ALLOGENE THERAP (ALLO)
NASDAQ
$2.01+$0.010 (+0.50%)
Price as of Jun 03, 2026 7:58 PM EDT- $749.0MMarket Cap
- 51.85%1-Year Change
- BiotechnologyIndustry
ALLOGENE THERAP (ALLO)
$2.01+$0.010 (+0.50%)
Earnings Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -22.66% | ||
12-Month Momentum | 69.29% | ||
3-Month Risk Adjusted Momentum | -47.91% | ||
12-Month Risk Adjusted Momentum | 81.60% |
True Yield
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.0007% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ALLO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |